Portal de Periódicos da CAPES

Cold atmospheric plasma and iron oxide-based magnetic nanoparticles for synergetic lung cancer therapy

2018; Elsevier BV; Volume: 130; Linguagem: Inglês

10.1016/j.freeradbiomed.2018.10.429

1873-4596

Wentong Li, Hongli Yu, Dejun Ding, Zhitong Chen, Yonghong Wang, Saisai Wang, Xujing Li, Michael Keidar, Weifen Zhang,

Plasma Diagnostics and Applications

Cold atmospheric plasma (CAP) is an emerging biomedical technique that shows great potential for cancer treatment. On the other hand, magnetic nanoparticles open up a wide field of possible applications in medicine. Here we seek to develop a novel dual cancer therapeutic method by integrating promising CAP and iron oxide-based magnetic nanoparticles (MNPs), and evaluate its underlying mechanism for targeted lung cancer treatment. For this purpose, the synergistic effects of CAP and iron oxide-based MNPs on cellular bioactivity, epidermal growth factor receptor (EGFR) expression, and EGFR downstream signaling pathways were investigated. Results showed that the effectiveness of CAP and iron oxide-based MNPs for synergistic strongly killed activity against lung cancer cells, and significantly inhibited cell proliferation via reduction of viability and induction of apoptosis. Importantly, CAP combining with iron oxide-based MNPs induced EGFR downregulation while CAP inhibited lung cancer cells via depressing pERK and pAKT. Translation of these findings to an in vivo setting demonstrates that CAP combining iron oxide-based MNPs is effective at preventing xenograft tumors. Thus, the integration of CAP and iron oxide-based MNPs provides a promising tool for the development of a new cancer treatment strategy.